Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
Track This Opportunity
Create an account to track opportunities.
About This Opportunity
This is a grant opportunity from the National Institutes of Health (NIH) for organizations to establish a clinical research network focused on antimicrobial resistance. Awardees will receive funding to conduct clinical trials (UM1 mechanism) aimed at combating drug-resistant infections. It's designed for research institutions or companies capable of leading significant clinical research efforts.
Eligibility Requirements
Application Guide
Selection will likely be based on scientific merit, proposed methodology, potential impact on antimicrobial resistance, investigator qualifications, and the feasibility of establishing a robust clinical trial network.
Emphasize the scientific rigor of your proposed clinical trials, clearly outline your network's structure and collaboration plan, and demonstrate your team's expertise in antimicrobial resistance research and clinical trial execution.
Geographic Coverage
Links & Resources
Source & freshness
Last verified: 9/13/2026
Primary source: Official source page
Refresh cadence: Listings are refreshed weekly.
Reminder: Confirm eligibility and deadlines before applying.